A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy

Developmental Medicine and Child Neurology

Volumn 54, Issue 10, 2012, Pages 879-885

  Mazzone, Elena S ^a   Vasco, Gessica ^a   Palermo, Concetta ^a   Bianco, Flaviana ^a   Galluccio, Carmen ^a   Ricotti, Valeria ^b   Castronovo, Antonella D ^a   Mauro, Maria Sole Di ^a   Pane, Marika ^a   Mayhew, Anna ^c   Mercuri, Eugenio ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABILHAND; ACTIVLIM; ARM MOVEMENT; BROOKE UPPER EXTREMITY SCALE; CLINICAL ASSESSMENT TOOL; DAILY LIFE ACTIVITY; DATA EXTRACTION; DUCHENNE MUSCULAR DYSTROPHY; EGEN KLASSIFICATION; ELECTRONIC MEDICAL RECORD; FUNCTIONAL ASSESSMENT; HUMAN; JEBSEN HAND FUNCTION TEST; LONGITUDINAL STUDY; MOTOR FUNCTION MEASURE; MUSCULAR DYSTROPHY FUNCTIONAL RATING SCALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; QUESTIONNAIRE; RELIABILITY; REVIEW; SELF REPORT; UPPER LIMB FUNCTIONAL ABILITY TEST; VALIDITY;

ACTIVITIES OF DAILY LIVING; CHILD; DISABILITY EVALUATION; HUMANS; MOTOR SKILLS DISORDERS; MUSCULAR DYSTROPHY, DUCHENNE; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOMOTOR DISORDERS; REPRODUCIBILITY OF RESULTS;

EID: 84866424753     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2012.04345.x     Document Type: Review

References (42)

1. Mercuri E, Mayhew A, Muntoni F, et al. Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th-13th May 2007, Naarden, The Netherlands; TREAT-NMD workshop on outcome measures in experimental trials for DMD, 30th June-1st July 2007, Naarden, The Netherlands; conjoint Institute of Myology TREAT-NMD meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France. Neuromuscul Disord 2008; 18: 894-903.
2. Muntoni F. The development of antisense oligonucleotide therapies for Duchenne muscular dystrophy: report on a TREAT-NMD workshop hosted by the European Medicines Agency (EMA), on September 25th 2009. Neuromuscul Disord 2010; 20: 355-62.
3. Bushby K, Connor E. Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings. Clin Invest 2011; 1: 1217-35.
4. Escolar DM, Henricson EK, Mayhew J, et al. Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve 2001; 24: 787-93.
5. Stuberg WA, Metcalf WK. Reliability of quantitative muscle testing in healthy children and in children with Duchenne muscular dystrophy using a hand-held dynamometer. Phys Ther 1988; 68: 977-82.
6. Lue YJ, Lin RF, Chen SS, Lu YM. Measurement of the functional status of patients with different types of muscular dystrophy. Kaohsiung J Med Sci 2009; 25: 325-33.
7. Escolar DM, Buyse G, Henricson E, et al. CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy. Ann Neurol 2005; 58: 151-5.
8. Escolar DM, Hache LP, Clemens PR, et al. Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy. Neurology 2011; 77: 444-52.
9. Spurney CF, Rocha CT, Henricson E, et al. CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy. Muscle Nerve 2011; 44: 174-8.
10. Mazzone ES, Messina S, Vasco G, et al. Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord 2009; 19: 458-61.
11. Mayhew A, Cano S, Scott E, et al. Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Dev Med Child Neurol 2011; 53: 535-42.
12. Mazzone E, Bianco F, Martinelli D, et al. Assessing upper limb function in nonambulant SMA patients: development of a new module. Neuromuscul Disord 2011; 21: 406-12.
13. Scott E, Eagle M, Mayhew A, et al. Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy. Physiother Res Int 2011 Sep 23 (Epub ahead of print).
14. Bérard C, Payan C, Hodgkinson I, Fermanian J. A motor function measure for neuromuscular diseases Construction and validation study Neuromuscul Disord 2005; 15: 463-70.
15. Vuillerot C, Girardot F, Payan C, et al. Monitoring changes and predicting loss of ambulation in Duchenne muscular dystrophy with the Motor Function Measure. Dev Med Child Neurol 2010; 52: 60-5.
16. McDonald CM, Henricson EK, Han JJ, et al. The 6-minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observations. Muscle Nerve 2010; 42: 966-74.
17. McDonald CM, Henricson EK, Han JJ, et al. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve 2010; 41: 500-10.
18. Mazzone E, Martinelli D, Berardinelli A, et al. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Neuromuscul Disord 2010; 20: 712-6.
19. Mazzone E, Vasco G, Sormani MP, et al. Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. Neurology 2011; 77: 250-6.
20. Vandervelde L, Van den Bergh PY, Goemans N, Thonnard JL. Activity limitations in patients with neuromuscular disorders: a responsiveness study of the ACTIVLIM questionnaire. Neuromuscul Disord 2009; 19: 99-103.
21. Uchikawa K, Liu M, Hanayama K, et al. Functional status and muscle strength in people with Duchenne muscular dystrophy living in the community. J Rehabil Med 2004; 36: 124-9.
22. Lue YJ, Su CY, Yang RC, et al. Development and validation of a muscular dystrophy-specific functional rating scale. Clin Rehabil 2006; 20: 804-17.
23. Lord JP, Portwood MM, Lieberman JS, et al. Upper extremity functional rating for patients with Duchenne muscular dystrophy. Arch Phys Med Rehabil 1987; 68: 151-4.
24. Hiller LB, Wade CK. Upper extremity functional assessment scales in children with Duchenne muscular dystrophy: a comparison. Arch Phys Med Rehabil 1992; 73: 527-34.
25. Brooke MH, Fenichel GM, Griggs RC, et al. Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology 1989; 39: 475-81.
26. Brooke MH, Griggs RC, Mendell JR, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve 1981; 4: 186-97.
27. Steffensen B, Hyde S, Lyager S, Mattsson E. Validity of the EK scale: a functional assessment of non-ambulatory individuals with Duchenne muscular dystrophy or spinal muscular atrophy. Physiother Res Int 2001; 6: 119-34.
28. Vandervelde L, Van den Bergh PY, Goemans N, Thonnard JL. ACTIVLIM: a Rasch-built measure of activity limitations in children and adults with neuromuscular disorders. Neuromuscul Disord 2007; 17: 459-69.
29. Zupan A. Assessment of the functional abilities of the upper limbs in patients with neuromuscular diseases. Disabil Rehabil 1996; 18: 69-75.
30. Jebsen RH, Taylor N, Trieschmann RB, et al. An objective and standardized test of hand function. Arch Phys Med Rehabil 1969; 50: 311-9.
31. Taylor N, Sand PL, Jebsen RH. Evaluation of hand function in children. Arch Phys Med Rehabil 1973; 54: 129-35.
32. Florence JM, Pandya S, King WM, et al. Clinical trials in Duchenne dystrophy Standardization and reliability of evaluation procedures. Phys Ther 1984; 64: 41-5.
33. Wagner MB, Vignos PJ Jr, Carlozzi C. Duchenne muscular dystrophy: a study of wrist and hand function. Muscle Nerve 1989; 12: 236-44.
34. Barr AE, Diamond BE, Wade CK, et al. Reliability of testing measures in Duchenne or Becker muscular dystrophy. Arch Phys Med Rehabil 1991; 72: 315-9.
35. Wagner MB, Vignos PJ Jr, Carlozzi C, Hull AL. Assessment of hand function in Duchenne muscular dystrophy. Arch Phys Med Rehabil 1993; 74: 801-4.
36. Bartels B, Pangalila RF, Bergen MP, et al. Upper limb function in adults with Duchenne muscular dystrophy. J Rehabil Med 2011; 43: 770-5.
37. Steffensen BF, Lyager S, Werge B, et al. Physical capacity in non-ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal study. Dev Med Child Neurol 2002; 44: 623-32.
38. van der Velde G, Beaton D, Hogg-Johnston S, et al. Rasch analysis provides new insights into the measurement properties of the neck disability index. Arthritis Rheum 2009; 61: 544-51.
39. Vandervelde L, Van den Bergh PY, Penta M, Thonnard JL. Validation of the ABILHAND questionnaire to measure manual ability in children and adults with neuromuscular disorders. J Neurol Neurosurg Psychiatry 2010; 81: 506-12.
40. Brooke MH, Fenichel GM, Griggs RC, et al. Clinical investigation of Duchenne muscular dystrophy Interesting results in a trial of prednisone. Arch Neurol 1987; 44: 812-7.
41. Mercuri E, Bushby K, McDonald C, et al. Disease progression observed in clinical outcome measures in placebo-treated patients with nonsense mutation dystrophinopathy. Neuromuscul Disord 2011; 20: 651.
42. Servais LCA, De Coninck N. Upper limb evaluation in non-ambulatory patients with neuromuscular disorders. Neuromuscul Disord 2011; 20: 669.